logo

For the Inventor, By the Inventor

London, United Kingdom

Imperial College Innovations Limited

Calculating rank
USPTO Granted Patents = 174

% Expired Patents = 16.1



Trademarks = 1

Forward Citations = 935

Loading Chart...
Loading Chart...

470 inventors (with patents filed for the assignee):

goldMedal Andrew Davison (8 out of 10 patents)

silverMedal Edward William Tate (6 out of 7 patents)

bronzeMedal Amin Hajitou (5 out of 5 patents)

4.  Andrew Simon Bell (5 out of 5 patents)

5.  Matthew John Fuchter (5 out of 13 patents)

6.  Michael Bloesch (5 out of 5 patents)

7.  Stefan Leutenegger (5 out of 5 patents)

8.  Prapa Kanagaratnam (4 out of 5 patents)

9.  Nagy Habib (4 out of 18 patents)

10.  Teerapong Yata (4 out of 4 patents)

11.  Pantelis Georgiou (4 out of 9 patents)

12.  George Mylonas (4 out of 6 patents)

13.  Anthony Dorling (4 out of 6 patents)

14.  Robert Ian Lechler (4 out of 5 patents)

15.  David William Holden (4 out of 17 patents)


Core Competencies:
Cancer
Natural Killer Cells
RNAi Therapy
Therapeutics
Immunotherapy
Compounds
Wound Treatment
Antibody
Inhibitors
Electrocardiogram
UAVs
Fluid Analysis

174 patents:

1. 12765827 - Electrophysiological catheter systems (2026-10-20),
2. 12742202 - METHOD FOR DETECTING A SINGLE NUCLEOTIDE POLYMORPHISM (SNP) USING LAMP AND BLOCKING PRIMERS (2026-09-22),
3. 12713736 - ENHANCED LIGHT EXTRACTION FROM LIGHT EMITTING DIODES UTILIZING A NANOPARTICLE META-GRID (2026-08-18),
4. 12708309 - IMPLANTABLE NEURAL INTERFACE (2026-08-18),
5. D1139980 - Valve for patient ventilator equipment (2026-08-04),
6. 12698521 - METHOD OF SELECTING A POLYPEPTIDE OF INTEREST (2026-08-04),
7. 12691121 - TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (2026-07-28),
8. 12691100 - NMT INHIBITOR TREATMENT OF A SENESCENCE-ASSOCIATED DISEASE OR DISORDER OF THE LIVER (2026-07-28),
9. 12661394 - CORONAVIRUS VACCINE (2026-06-23),
10. 12637458 - Imidazo[1,2-a]pyridine compounds and their use in therapy (2026-05-26),
11. 12637370 - Electrochemical cell (2026-05-26),
12. 12622593 - Pressure sensor (2026-05-12),
13. 12618844 - Cancer (2026-05-05),
14. 12603471 - Apparatus and method for adjusting the wavelength of light (2026-04-14),
15. 12599676 - CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY (2026-04-14),
Company Overview
Imperial College Innovations Limited, based in London, specializes in advancing cancer therapeutics through innovative research and development. The organization focuses on harnessing the potential of natural killer cells and RNA interference therapy to create effective immunotherapies and compounds aimed at treating various forms of cancer. Additionally, it explores applications in wound treatment, emphasizing the integration of cutting-edge scientific discoveries into therapeutic solutions that address critical healthcare challenges.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

Imperial College Innovations Limited USPTO Patent Assignee Logo
174 Patents

#33 in London

#96 in United Kingdom

#4,775 in the World

London, GB
London, United Kingdom

Imperial College Innovations Limited

Forward Citations = 935

470 inventors:

goldMedal Andrew Davison (8 out of 10 patents)

silverMedal Edward William Tate (6 out of 7 patents)

bronzeMedal Amin Hajitou (5 out of 5 patents)

4.  Andrew Simon Bell (5 out of 5 patents)

5.  Matthew John Fuchter (5 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Imperial College Innovations Limited. Retrieved from https://idiyas.com/company/imperial-college-innovations

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…